Systematic reviews including this primary study

loading
2 articles (2 References) loading Revert Studify

Systematic review

Unclassified

What is the risk of sham surgery in Parkinson disease clinical trials? A review of published reports.

Authors Frank S , Kieburtz K , Holloway R , Kim SY
Journal Neurology
Year 2005
Links Pubmed DOI

This article includes 4 Primary studies 4 Primary studies (4 references)

Loading references information
Placebo, or sham surgery, as a control condition in surgical clinical trials in Parkinson disease (PD) remains controversial. The authors reviewed the adverse effects reported in double blind, placebo surgery controlled trials for PD. Placebo surgeries were generally safe and well tolerated but the number of subjects receiving the procedure was small. Harm occurred more frequently in subjects randomized to the experimental intervention.

Systematic review

Unclassified

Reconstructive neurosurgery for Parkinson's disease: a systematic review and preliminary meta-analysis.

blocked
Journal Brain research bulletin
Year 2003
Links Pubmed DOI

This article includes 23 Primary studies 23 Primary studies (23 references)

Loading references information
This systematic review and meta-analysis aimed to identify the determinants for best practice and establish current benchmarks for recovery following reconstructive neurosurgery for people with Parkinson's disease. Eleven studies reporting results for 95 grafted patients were selected on the grounds of using optimal surgical techniques and the Core Assessment Program for Intracerebral Transplantation (CAPIT) protocol for data collection. Consistent trends demonstrating high levels of recovery were identified on most outcome measures. Determinants for best practice were identified as selecting younger patients; using low dose immunosuppression; bilateral grafting; and employing strategies to ensure the quantity and viability of the grafted cells. Secondary analysis of data demonstrated a correlation of rho=0.666 (P<0.05) between increases in striatal dopaminergic activity and UPDRS Motor (off) scores. Overall effect size 'd' was found to be 1.129 UPDRS Motor (off) condition and 0.719 for UPDRS Total (off) condition. The design of the studies and the variable standards for reporting the data precluded the use of more powerful and accurate meta-analyses. It was recommended that the creation of a collaborative database would improve the extraction of data and allow for more powerful statistical analyses for evaluating the overall harm and benefits associated with reconstructive neurosurgery.